In the BioHarmony Drug Report Database

"Preview" Icon

Betrixaban

Bevyxxa (betrixaban) is a small molecule pharmaceutical. Betrixaban was first approved as Bevyxxa on 2017-06-23. The pharmaceutical is active against coagulation factor X. Bevyxxa’s patents are valid until 2031-03-29 (FDA).

 

Trade Name

 

Bevyxxa
 

Common Name

 

betrixaban
 

ChEMBL ID

 

CHEMBL512351
 

Indication

 

 

Drug Class

 

Antithrombotic: blood coagulation factor XA inhibitors

Image (chem structure or protein)

Betrixaban structure rendering